Aurora kinase B inhibition in small-cell lung cancer: BCL-2 as a potential therapeutic biomarker and combination target

Transl Lung Cancer Res. 2024 Mar 29;13(3):689-693. doi: 10.21037/tlcr-23-754. Epub 2024 Mar 15.NO ABSTRACTPMID:38601438 | PMC:PMC11002497 | DOI:10.21037/tlcr-23-754

Source: Cell Research - April 11, 2024 Category: Cytology Authors: Kazutaka Hosoya Hiroaki Ozasa Source Type: research